# Thiamine Supplement in Patients With Severe Hyperthyroidism

> **NCT02767245** · NA · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 12 (actual)

## Conditions studied

- Thyrotoxicosis

## Interventions

- **DRUG:** Thiamine

## Key facts

- **NCT ID:** NCT02767245
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767245, "Thiamine Supplement in Patients With Severe Hyperthyroidism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02767245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*